<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001688327</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001819133</issuerCik>
      <issuerName>Tango Therapeutics, Inc.</issuerName>
      <secFileNumber>001-39485</secFileNumber>
      <issuerAddress>
        <com:street1>201 BROOKLINE AVENUE</com:street1>
        <com:street2>SUITE 901</com:street2>
        <com:city>BOSTON</com:city>
        <com:stateOrCountry>MA</com:stateOrCountry>
        <com:zipCode>02215</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>(857) 320-4900</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Third Rock Ventures IV, L.P.</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>10% Stockholder</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>BTIG, LLC</name>
        <address>
          <com:street1>350 Bush Street</com:street1>
          <com:street2>9th Floor</com:street2>
          <com:city>San Francisco</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94104</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>302194</noOfUnitsSold>
      <aggregateMarketValue>2085138.60</aggregateMarketValue>
      <noOfUnitsOutstanding>111260247</noOfUnitsOutstanding>
      <approxSaleDate>08/22/2025</approxSaleDate>
      <securitiesExchangeName>NASDAQ GM</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>03/23/2017</acquiredDate>
      <natureOfAcquisitionTransaction>Pre-IPO investment</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Tango Therapeutics Inc</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>302194</amountOfSecuritiesAcquired>
      <paymentDate>03/23/2017</paymentDate>
      <natureOfPayment>Wire</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Third Rock Ventures IV, L.P.</name>
        <address>
          <com:street1>201 BROOKLINE AVENUE</com:street1>
          <com:street2>Suite 1401</com:street2>
          <com:city>BOSTON</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02215</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <saleDate>08/19/2025</saleDate>
      <amountOfSecuritiesSold>1100000</amountOfSecuritiesSold>
      <grossProceeds>7712760.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>08/22/2025</noticeDate>
      <signature>Kevin Gillis</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
